These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7503005)

  • 21. [Treatment of malignant ventricular arrhythmia guided by electrophysiologic study].
    Brandão L; Carpinteiro L; Sousa J; Vagueiro MC
    Acta Med Port; 1998 Jan; 11(1):9-16. PubMed ID: 9580363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction.
    Nasir N; Taylor A; Doyle TK; Pacifico A
    Am J Cardiol; 1994 Dec; 74(12):1183-6. PubMed ID: 7977086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias.
    Nalliah CJ; Zaman S; Narayan A; Sullivan J; Kovoor P
    Europace; 2014 Jul; 16(7):1053-60. PubMed ID: 24158256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM trial).
    Olshansky B; Hartz V; Hahn E; Mason J; Weaver MD;
    Am J Cardiol; 2000 Oct; 86(8):846-51. PubMed ID: 11024399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report.
    Akiyama J; Tomizawa T; Umezawa S; Morishima A
    Jpn Circ J; 1999 Apr; 63(4):323-5. PubMed ID: 10475784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of class Ia/Ib versus class III antiarrhythmic drugs for the suppression of inducible sustained ventricular tachycardia associated with coronary artery disease.
    Khalighi K; Peters RW; Feliciano Z; Shorofsky SR; Gold MR
    Am J Cardiol; 1997 Sep; 80(5):591-4. PubMed ID: 9294987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction.
    Zaman S; Kumar S; Sullivan J; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):884-90. PubMed ID: 23995117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F; Scheinman MM; Hess DS; Sung RJ; Shen E; Shapiro W
    Am J Cardiol; 1983 Jan; 51(1):85-9. PubMed ID: 6849269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction.
    Mont L; Cinca J; Blanch P; Blanco J; Figueras J; Brotons C; Soler-Soler J
    J Am Coll Cardiol; 1996 Dec; 28(7):1670-6. PubMed ID: 8962550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for cardiac mortality in cases of syncope with previous history of myocardial infarction].
    Brembilla-Perrot B; Suty-Selton C; Alla F; Beurrier D; Houriez P; Claudon O; Terrier de la Chaise A; Louis P; Sadoul N; Andronache M; Miltjoen H; Juillière Y
    Arch Mal Coeur Vaiss; 2003 Dec; 96(12):1181-6. PubMed ID: 15248444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy for late post infarction ventricular tachycardia.
    Somberg JC; Butler B; Torres V; Tepper D; Keren G; Siegel L; Jentzer J; Miura DS
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].
    Steinbeck G; Andresen D; von Leitner ER
    Z Kardiol; 1986; 75 Suppl 5():47-55. PubMed ID: 2435071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure.
    Sartipy U; Albåge A; Strååt E; Insulander P; Lindblom D
    Ann Thorac Surg; 2006 Jan; 81(1):65-71. PubMed ID: 16368337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.